Cerebrospinal fluid levels of β endorphin in painful and painless diabetic polyneuropathy

Journal of Diabetes and Its Complications

Volumn 9, Issue 2, 1995, Pages 92-96

  Tsigos, Constantine ^a   Gibson, Sarah ^a   Crosby, Steven R ^a   White, Anne ^a   Young, Robert J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BETA ENDORPHIN; MONOCLONAL ANTIBODY; OPIATE; PROOPIOMELANOCORTIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; NOCICEPTION; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT FAILURE;

BETA-ENDORPHIN; COHORT STUDIES; COMPARATIVE STUDY; DIABETIC NEUROPATHIES; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGE; PAIN; PRO-OPIOMELANOCORTIN; PROBABILITY; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T;

EID: 0028922749     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(94)00024-I     Document Type: Article

References (27)

1. Pain in peripheral neuropathy: Clinical and morphological aspects
2. Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain
3. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration
4. Cerebrospinal fluid levels of substance P and calcitonin-gene-related peptide: Correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy
5. Plasma norepinephrine in sensory diabetic polyneuropathy
6. Thalamic relay nucleus stimulation for relief of intractable pain. Clinical results and beta-endorphin immunoreactivity in the cerebrospinal fluid
7. Beta-endorphin and somatostatin concentrations in the ventricular cerebrospinal fluid of patients with affective disorders
8. Simultaneous determination of radio-immuno-assayable methionin-enkephalin and radioreceptor active opioid peptides in CSF of chronic pain suffering and non-suffering patients
9. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry
10. Neuroendocrinology of cerebrospinal fluid: Peptides, steroids and other hormones
11. Endogenous opioids and related derivatives
12. Significance of opioid peptides and other potential markers of neuropeptide systems in cerebrospinal fluid
13. Common precursor to corticotropins and endorphins
14. Discrimination between painful and painless diabetic neuropathy based on testing of large somatic nerve and sympathetic nerve function
15. A portable system for measuring cutaneous thresholds for warming and cooling
16. Diagnosis and management of diabetic autonomic neuropathy
17. Detection of β-endorphin with a specific immunoradiometric assay
18. Proopiomelanocortin is the predominant ACTH-related peptide in human cerebrospinal fluid
19. Morphine-like ligand for opiate receptors in human CSF
20. Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes
21. Neurochemical basis of acupuncture analgesia
22. Post-operative increase of cerebrospinal fluid beta-endorphin-like immunoreactivity levels
23. Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis
24. Immunoreactive β-endorphin and adrenocorticotropin in human cerebrospinal fluid
25. Neuropeptides in human cerebrospinal fluid
26. Genetic control of hormone formation
27. CNS manifestations of diabetes mellitus